WELCOME TO NEWS EIGHT AT TEN. I’M JERRY GISH, AND I’M THASMEEN MAHFUZ. WE’RE FOLLOWING SEVERAL KEY SCHOOL BOARD RACES ACROSS CUMBERLAND, LANCASTER AND YORK COUNTIES. NEWS EIGHT’S MCKENNA ALEXANDER IS ...

Allen West’s resignation last week as Dallas County GOP chair, announced ahead of an executive committee meeting that was expected to call for his removal, should have closed a chapter of dysfunction ...

Please provide your email address to receive an email when new articles are posted on . Implementing a shared decision-making aid in lung cancer care is feasible. Clinicians reported they valued the ...

Kentucky's 2026 primary election is scheduled for Tuesday, May 19. The deadline to register to vote is April 20. Excused, in-person absentee voting will be available on select dates in early May.

Microsoft Corp. aims to develop large, cutting-edge artificial intelligence models by next year, part of a push to build in-house alternatives to the most powerful AI tools from OpenAI and Anthropic. ...

SpaceX seems to be getting a step closer to a blockbuster initial public offering. Elon Musk’s aerospace firm has submitted its draft IPO registration to the U.S. Securities and Exchange Commission, ...

South Carolina's 2026 elections feature competitive races for governor, one U.S. Senate seat, and all seven House seats. With Gov. Henry McMaster term-limited, seven Republicans and three Democrats ...

Chris is a Senior News Writer for Collider. He can be found in an IMAX screen, with his eyes watering and his ears bleeding for his own pleasure. He joined the news team in 2022 and accidentally fell ...

New tools in Gemini give users prompts to quickly copy over everything their previous chatbot knows about them. New tools in Gemini give users prompts to quickly copy over everything their previous ...

PROGRESS AND NEW INVESTMENTS UNDERWAY. WHETHER YOU ARE A CHEF IN LOUISIANA OR WHETHER YOU ARE DRIVING A VEHICLE IN MICHIGAN, CHANCES ARE IT STARTED IN THE PORT OF BALTIMORE, MARYLAND. ECONOMIC ENGINE ...

Abivax (ABVX) shares fell on Tuesday following the company’s 2025 financials, as its CEO suggested that the biotech is not rushing to pursue deals ahead of a key late-stage trial readout for its lead ...